Cargando…
N(1)-Methylnicotinamide Improves Hepatic Insulin Sensitivity via Activation of SIRT1 and Inhibition of FOXO1 Acetylation
OBJECTIVE: To explore the effects of N(1)-methylnicotinamide (MNAM) on insulin resistance and glucose metabolism in obese type 2 diabetes mellitus (T2DM) mice and regulatory mechanisms of the NAD-dependent deacetylase sirtuin-1 (SIRT1)/forkhead box protein O1 (FOXO1) pathway. METHODS: Blood glucose...
Autores principales: | Zhang, Jingfan, Chen, Yu, Liu, Cong, Li, Ling, Li, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125486/ https://www.ncbi.nlm.nih.gov/pubmed/32280711 http://dx.doi.org/10.1155/2020/1080152 |
Ejemplares similares
-
Serum N(1)-methylnicotinamide is Associated with Left Ventricular Systolic Dysfunction in Chinese
por: Liu, Ming, et al.
Publicado: (2018) -
Serum N
(1)‐Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients
por: Liu, Ming, et al.
Publicado: (2017) -
Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension
por: Fedorowicz, Andrzej, et al.
Publicado: (2016) -
1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer
por: Kilgour, Marisa K., et al.
Publicado: (2021) -
N(1)-methylnicotinamide is a signalling molecule produced in skeletal muscle coordinating energy metabolism
por: Ström, Kristoffer, et al.
Publicado: (2018)